Design Therapeutics, Inc. (DSGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.93
Day's range
$10.43

Design Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SR ONE CAPITAL MANAGEMENT, LP 08/12/2026 6.53 M $94.44 M   0.00% 10.62%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 3.00 M $43.41 M   53.85% 4.88%
BAKER BROS. ADVISORS LP 08/14/2026 2.68 M $38.76 M   3.58% 4.36%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 2.66 M $38.51 M   52.50% 4.33%
BLACKROCK, INC. 08/07/2026 2.66 M $38.49 M   24.66% 4.33%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 2.37 M $34.24 M   -13.09% 3.85%
TRAILS EDGE CAPITAL PARTNERS, LP 08/14/2026 2.00 M $28.96 M   134.89% 3.26%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 1.81 M $26.19 M   100.00% 2.95%
VIVO CAPITAL, LLC 08/14/2026 1.61 M $23.34 M   0.00% 2.63%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.57 M $22.73 M   16.38% 2.56%
CAPTION MANAGEMENT, LLC 08/14/2026 1.50 M $21.71 M   100.00% 2.44%
CAPTION MANAGEMENT, LLC 08/14/2026 1.12 M $16.18 M   1,189.50% 1.82%
ALMITAS CAPITAL LLC 08/17/2026 1.03 M $14.86 M   -32.90% 1.67%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 958.42 K $13.87 M   38.40% 1.56%
SOFINNOVA INVESTMENTS, INC. 08/14/2026 865.14 K $12.52 M   100.00% 1.41%
FMR LLC 08/13/2026 776.46 K $11.24 M   -2.75% 1.26%
MORGAN STANLEY 08/13/2026 765.43 K $11.08 M   16.58% 1.25%
STATE STREET CORP 08/07/2026 736.22 K $10.65 M   11.62% 1.20%
WOODLINE PARTNERS LP 08/14/2026 700.35 K $10.13 M   -27.16% 1.14%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 694.74 K $10.05 M   60.88% 1.13%
GOLDMAN SACHS GROUP INC 08/14/2026 656.58 K $9.50 M   30.09% 1.07%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 565.60 K $8.18 M   95.45% 0.92%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 537.48 K $7.77 M   -12.82% 0.87%
SIREN, L.L.C. 08/13/2026 523.21 K $7.57 M   100.00% 0.85%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 437.08 K $6.32 M   1,178.64% 0.71%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 387.91 K $5.61 M   -4.97% 0.63%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 384.04 K $5.56 M   41.42% 0.63%
NORTHERN TRUST CORP 08/13/2026 353.20 K $5.11 M   17.62% 0.57%
ALGERT GLOBAL LLC 08/13/2026 296.09 K $4.28 M   44.62% 0.48%
ACUTA CAPITAL PARTNERS, LLC 08/14/2026 282.56 K $4.09 M   93.67% 0.46%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 271.26 K $3.93 M   12.33% 0.44%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 271.26 K $3.93 M   100.00% 0.44%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 251.44 K $3.64 M   81.46% 0.41%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 230.20 K $3.33 M   17.66% 0.37%
PRUDENTIAL FINANCIAL INC 08/12/2026 224.17 K $3.24 M   389.35% 0.36%
D. E. SHAW & CO., INC. 08/14/2026 195.65 K $2.83 M   -58.40% 0.32%
EVERSEPT PARTNERS, LP 08/14/2026 190.00 K $2.75 M   100.00% 0.31%
KVP CAPITAL ADVISORS, LP 08/13/2026 185.00 K $2.68 M   100.00% 0.30%
J. GOLDMAN & CO LP 08/14/2026 176.77 K $2.56 M   100.00% 0.29%
MILLENNIUM MANAGEMENT LLC 08/14/2026 147.71 K $2.14 M   35.61% 0.24%
RAYMOND JAMES FINANCIAL INC 08/14/2026 138.52 K $2.00 M   27.73% 0.23%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 111.10 K $1.61 M   100.00% 0.18%
ELMIND CAPITAL, LP 08/14/2026 107.90 K $1.56 M   -48.10% 0.18%
NUVEEN, LLC 08/11/2026 104.73 K $1.52 M   -17.41% 0.17%
DAFNA CAPITAL MANAGEMENT LLC 08/14/2026 102.60 K $1.48 M   100.00% 0.17%
BANK OF NEW YORK MELLON CORP 08/06/2026 92.07 K $1.33 M   15.60% 0.15%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 07/24/2026 89.94 K $1.30 M   156.17% 0.15%
CITADEL ADVISORS LLC 08/14/2026 81.97 K $1.19 M   -64.59% 0.13%
SUMMITTX CAPITAL, L.P. 08/14/2026 80.66 K $1.17 M   100.00% 0.13%
AMERICAN CENTURY COMPANIES INC 08/12/2026 76.83 K $1.11 M   17.04% 0.13%

Design Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 167 institutional investors and hedge funds held shares of Design Therapeutics Inc. The most heavily invested institutionals were:

SR ONE CAPITAL MANAGEMENT, LP: 6.53 M

Logos Global Management LP: 3 M

BAKER BROS. ADVISORS LP: 2.68 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 2.66 M

BlackRock, Inc.: 2.66 M

Point72 Asset Management, L.P.: 2.37 M

70.93% of Design Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 47.75 M shares in the last 24 months. This purchase volume represents approximately $495.20 M in transactions.